ALTERNATIVES TO PROTEIN A: Improved Downstream Process Design for Human Monoclonal Antibody Production - A two-step process—a cation exchange capture column followed by anion exchange flow-throu

ADVERTISEMENT

ALTERNATIVES TO PROTEIN A: Improved Downstream Process Design for Human Monoclonal Antibody Production
A two-step process—a cation exchange capture column followed by anion exchange flow-through membrane chromatography—resulted in >80% process yield, higher batch capacity, and shorter process time.


BioPharm International


References

1. Adamson SR. A new era in biotechnology. BioProcess International Conference. San Francisco CA; 2006 November 6–9.

2. Gottschalk U. The renaissance of protein purification. Supplement to BioPharm Int. 2006 June:8–9.

3. Sofer G, Chirica LC. Improving productivity in downstream processing. BioPharm Int. 2006 Nov 19; (11):48–55.

4. Zhou JX, Tressel T. Membrane chromatography as a robust purification system for large-scale antibody production. Supplement to BioProcess Int. 2005 Sept 3; (9):32–37.

5. Cacciuttolo MA, Arunakumari A. Scale-up considerations for biotechnology-derived products. In: Michael Levin, editor. Drugs and the pharmaceutical Sciences, Vol 157, Pharmaceutical process scale-up, 2nd ed. Chapter 5. Boca Raton, FL: CRC Press, 2006.

6. Arunakumari A. Integrating high titer cell culture processes with highly efficient purification processes for the manufacturing of human monoclonal antibodies. BioProcess International Conference. San Francisco CA; 2006 Nov 6–9.

7. Jagschies G, Grönberg A, Björkman T, Lacki K, Johansson HJ. Technical and economical evaluation of downstream processing options for monoclonal antibody (MAb) production. Supplement to BioPharm Int. 2006 June:10–19.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Novartis Sells Influenza Vaccine Business to CSL for $275 Million
October 27, 2014
Author Guidelines
Source: BioPharm International,
Click here